Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Aleksandra Łacko"'
Autor:
Aleksandra Ciarka, Michał Kunc, Marta Popęda, Aleksandra Łacko, Barbara Radecka, Marcin Braun, Joanna Pikiel, Maria Litwiniuk, Katarzyna Pogoda, Ewa Iżycka-Świeszewska, Anna Zeller, Magdalena Niemira, Rafał Pęksa, Wojciech Biernat, Elżbieta Senkus
Publikováno v:
Contemporary Oncology, Vol 28, Iss 1, Pp 75-83 (2024)
Externí odkaz:
https://doaj.org/article/747de89e46a2493a8139c1c93606b528
Autor:
Michał Kunc, Marta Popęda, Anna Szałkowska, Magdalena Niemira, Michał Bieńkowski, Rafał Pęksa, Aleksandra Łacko, Barbara S. Radecka, Marcin Braun, Joanna Pikiel, Maria Litwiniuk, Katarzyna Pogoda, Ewa Iżycka-Świeszewska, Adam Krętowski, Anna J. Żaczek, Wojciech Biernat, Elżbieta Senkus-Konefka
Publikováno v:
Diagnostics, Vol 10, Iss 9, p 617 (2020)
Estrogen (ER) and progesterone (PgR) receptors and HER2 are crucial in the assessment of breast cancer specimens due to their prognostic and predictive significance. Single hormone receptor-positive breast cancers are less common and their clinical c
Externí odkaz:
https://doaj.org/article/9d6e2c4d318141e79d12685c05a99e7c
Autor:
Aleksandra Łacko, Ewelina Łata, Jolanta Szelachowska, Agnieszka Hałoń, Elzbieta Suder, Rafał Matkowski, Iwona Gisterek, Przemysław Biecek, Jan Kornafel
Publikováno v:
Folia Histochemica et Cytobiologica, Vol 48, Iss 1, Pp 78-83 (2010)
The aim of the study was to evaluate the prognostic value of the vascular endothelial growth factor A (VEGF-A) and hepatocyte growth factor receptor (HGFR, c-met) expressions in homogenous group of breast cancer patients. Tumor samples were collected
Externí odkaz:
https://doaj.org/article/6fcc30eb277f45998039187f6d276034
Autor:
Michał Kunc, Marta Popęda, Michał Bieńkowski, Marcin Braun, Aleksandra Łacko, Barbara Radecka, Joanna Pikiel, Maria Litwiniuk, Katarzyna Pogoda, Magdalena Niemira, Anna Szałkowska, Ewa Iżycka-Świeszewska, Gabor Cserni, Wojciech Biernat, Elżbieta Senkus
Publikováno v:
Cancer Research. 83:P2-23
Background: Single hormone receptor-positive breast cancers (BCs) display two distinct phenotypes: ER+/PgR– and ER–/PgR+ further stratified by their HER2 status. Their molecular features are not well defined. Our study aimed to identify different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f25249027d630e4b02dc6ad47452a87
https://doi.org/10.1158/1538-7445.sabcs22-p2-23-06
https://doi.org/10.1158/1538-7445.sabcs22-p2-23-06
Autor:
Simona, Borstnar, Marketa, Palacova, Aleksandra, Łacko, Constanta, Timcheva, Einav Nili, Gal-Yam, Konstantinos, Papazisis, Juraj, Beniak, Pavol, Kudela, Gábor, Rubovszky
Publikováno v:
Radiology and Oncology. 56:238-247
Background The CDK4/6 inhibitor, ribociclib in combination with endocrine therapy significantly improved progression-free survival in the first line setting in post-menopausal patients with HR+/HER2− advanced breast cancer (ABC) in a pivotal phase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6bef7489d337e5c12a07efe7583179c
https://doi.org/10.2478/raon-2022-0020
https://doi.org/10.2478/raon-2022-0020
Autor:
Michał Kunc, Rafał Pęksa, Gabor Cserni, Ewa Iżycka-Świeszewska, Aleksandra Łacko, Barbara Radecka, Marcin Braun, Joanna Pikiel, Maria Litwiniuk, Katarzyna Pogoda, Anna Szwajkosz, Wojciech Biernat, Elżbieta Senkus
Publikováno v:
Pathology. 54(3):269-278
Oestrogen receptor (ER)-negative (–) progesterone receptor (PgR)-positive (+) is the least common combination of steroid receptor expression observed in breast cancer. There are many controversies regarding the actual existence of ER–/PgR+ phenot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11440d73ea6bcc28a4b3b2d2d2a1e50b
https://doi.org/10.1016/j.pathol.2021.10.003
https://doi.org/10.1016/j.pathol.2021.10.003
Autor:
Dorota Dupla, Elżbieta Senkus, Zbigniew Nowecki, Adam Maciejczyk, Piotr Kasprzak, Rafal Matkowski, Wojciech M. Wysocki, Aleksandra Łacko
Publikováno v:
Nowotwory. Journal of Oncology. 70:77-84
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c59768bb0c896167386d7f94171ce42
https://doi.org/10.5603/njo.a2020.0018
https://doi.org/10.5603/njo.a2020.0018
Should adjuvant radiotherapy be used in patients with early stage Hodgkin’s lymphoma? A vote for yes
Autor:
Aleksandra Łacko, Ewelina Łata-Woźniak
Publikováno v:
Nowotwory. Journal of Oncology. 70:29-32
Hodgkin’s lymphoma (HL) belongs to the most radiosensitive and chemosensitive cancers. Combined modality therapy is the preferred treatment for patients with classical favorable early-stage HL. However, late toxicity still remains an issue. A moder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb932966f8b71d446529e48f78bc23a0
https://doi.org/10.5603/njo.2020.0006
https://doi.org/10.5603/njo.2020.0006
Autor:
Icro Meattini, Elżbieta Senkus, Orit Kaidar-Person, Aleksandra Łacko, Maria João Cardoso, Philip Poortmans
Publikováno v:
Cancer treatment reviews
Introduction of sentinel lymph node biopsy, initially in clinically node-negative and subsequently in patients presenting with involved axilla and downstaged by primary systemic therapy, allowed for significant decrease in morbidity compared to axill
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16cfbb16cb6367279676911929c5decf
https://doi.org/10.1016/j.ctrv.2021.102297
https://doi.org/10.1016/j.ctrv.2021.102297
Autor:
Wojciech M. Wysocki, Aleksandra Łacko
Publikováno v:
Nowotwory. Journal of Oncology. 68:38-41
Over the years the surgical management of localized breast cancer has become less aggressive. Complete resection of the primary tumour with negative margins replaced mastectomy and is currently a standard of care in a vast majority of women with ea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::657c105288fa2ba9d216b569ff5b4537
https://doi.org/10.5603/njo.2018.0008
https://doi.org/10.5603/njo.2018.0008